Skip to main content
VCbacked
Log inGet Started

Sharp Therapeutics

Pittsburgh, United States

Sharp Therapeutics is engaged in the development of biosensors for cellular biology research and high-throughput screening.

$1.6M raised
Feb 2026
Post-IPO Debt
BiotechnologyLife ScienceMedical Device

Top Investors

Innovation WorksSTX PARTNERSNewlin Investment CompanyScott F. SneddonBrooks Family Office

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sharp Therapeutics

How much funding has Sharp Therapeutics raised?
Sharp Therapeutics has raised $1.6M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in February 2026.
Who are Sharp Therapeutics's investors?
Sharp Therapeutics's investors include Innovation Works, STX PARTNERS, Newlin Investment Company, Scott F. Sneddon, Brooks Family Office.
Where is Sharp Therapeutics headquartered?
Sharp Therapeutics is headquartered in Pittsburgh, United States.
What does Sharp Therapeutics do?
Sharp Therapeutics is engaged in the development of biosensors for cellular biology research and high-throughput screening.
What stage is Sharp Therapeutics at?
Sharp Therapeutics is at the Post-IPO Debt stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Sharp Therapeutics — Funding & Investors." VCBacked, February 27, 2026, https://www.vcbacked.co/company/sharp-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2026). Sharp Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/sharp-therapeutics
Wikipedia (cite web)
{{cite web |title=Sharp Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/sharp-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
Renaissance BioScience
Vancouver$599K
AlpalifeBio
Woburn$9.8M
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K